SigmaDrugs Research Ltd.
1 clinical trials · Sponsor
◉ Watch SigmaDrugs Research Ltd.
| Record | Firm | Date |
|---|---|---|
| Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients (NCT04718480) | SigmaDrugs Research Ltd. | 2020-11-27 |
Track SigmaDrugs Research Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.